Brooks Laboratories Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	1.5yrs
Board average tenure	5.6yrs

Recent management updates

Recent updates

CEO

Brooks Laboratories has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Prashant Rathi	Chief Financial Officer	3.8yrs	₹3.22m	no data
Jai Vaidya	Company Secretary & Compliance Officer	1.5yrs	₹183.00k	no data
Jitendra Singh	Whole Time Director	1.5yrs	₹277.33k	no data
Saras Gupta	General Manager of Marketing	no data	no data	3.07% ₹ 82.2m
Durga Maity	Whole Time Director	less than a year	₹19.00k	no data
Bhushan Rana	Whole-Time Director	less than a year	no data	no data

1.5yrs

Average Tenure

49yo

Average Age

Experienced Management: BROOKS's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Jitendra Singh	Whole Time Director	1.5yrs	₹277.33k	no data
Durga Maity	Whole Time Director	less than a year	₹19.00k	no data
Bhushan Rana	Whole-Time Director	less than a year	no data	no data
Rajnish Bedi	Independent Director	12yrs	₹120.00k	no data
Deepak Mahajan	Independent Lead Director	10.7yrs	₹120.00k	0.0011% ₹ 29.2k
Sonia Gupta	Independent Director	9.7yrs	₹120.00k	no data

5.6yrs

Average Tenure

53.5yo

Average Age

Experienced Board: BROOKS's board of directors are considered experienced (5.6 years average tenure).

Brooks Laboratories Management

Management criteria checks 1/4

Key information

Recent management updates

Brooks Laboratories Limited Announces Director Appointments

Brooks Laboratories Limited, Annual General Meeting, Sep 21, 2023

Brooks Laboratories Limited, Annual General Meeting, Sep 21, 2023

Brooks Laboratories Limited Approves the Appointment of Bhushan Singh Rana as an Additional Director (Executive)

Brooks Laboratories Limited Appoints Durga Shankar Maity as Additional Director

Brooks Laboratories Limited Appoints Kaushalya Singh as a Whole Time Director of the Company

Recent updates

Third quarter 2024 earnings released: ₹1.51 loss per share (vs ₹2.03 loss in 3Q 2023)

Brooks Laboratories Limited to Report Q3, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings released: ₹0.64 loss per share (vs ₹3.19 loss in 2Q 2023)

Brooks Laboratories Limited Announces Director Appointments

Brooks Laboratories Limited, Annual General Meeting, Sep 21, 2023

Brooks Laboratories Limited, Annual General Meeting, Sep 21, 2023

New minor risk - Shareholder dilution

Brooks Laboratories Limited Approves the Appointment of Bhushan Singh Rana as an Additional Director (Executive)

First quarter 2024 earnings released: ₹1.81 loss per share (vs ₹3.80 loss in 1Q 2023)

Brooks Laboratories Limited to Report Q1, 2024 Results on Aug 10, 2023

Brooks Laboratories Limited Appoints Durga Shankar Maity as Additional Director

Third quarter 2023 earnings released: ₹2.03 loss per share (vs ₹3.14 loss in 3Q 2022)

Brooks Laboratories Limited Appoints Kaushalya Singh as a Whole Time Director of the Company

Brooks Laboratories Limited Announces Resignation of Atul Ranchal as Chairman, Effective on November 23, 2022

Would Brooks Laboratories (NSE:BROOKS) Be Better Off With Less Debt?

Brooks Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

First quarter 2023 earnings released: ₹3.80 loss per share (vs ₹0.47 loss in 1Q 2022)

Does Brooks Laboratories (NSE:BROOKS) Have A Healthy Balance Sheet?

Full year 2022 earnings released: ₹7.82 loss per share (vs ₹7.84 loss in FY 2021)

Jyoti Sancheti Resigns as Company Secretary & Compliance Officer of Brooks Laboratories Limited, with Effect from 7 June, 2022

Brooks Laboratories Limited to Report Q4, 2022 Results on May 30, 2022

Estimating The Intrinsic Value Of Brooks Laboratories Limited (NSE:BROOKS)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Brooks Laboratories Limited to Report Q3, 2022 Results on Feb 14, 2022

Is Brooks Laboratories (NSE:BROOKS) Using Too Much Debt?

Second quarter 2022 earnings released: ₹1.97 loss per share (vs ₹1.35 profit in 2Q 2021)

Less than half of directors are independent

Technical Director & Whole Time Director Suresh Garg has left the company

Insufficient new directors

Is Brooks Laboratories (NSE:BROOKS) A Risky Investment?

Full year 2021 earnings released: ₹7.76 loss per share (vs ₹13.84 loss in FY 2020)

Third quarter 2021 earnings released: ₹1.03 loss per share (vs ₹1.67 loss in 3Q 2020)

New 90-day low: ₹58.60

Brooks Laboratories Limited to Report Q3, 2021 Results on Feb 11, 2021

Here's Why Brooks Laboratories (NSE:BROOKS) Can Afford Some Debt

New 90-day high: ₹73.20

New 90-day high: ₹71.75

New 90-day high: ₹68.75

Brooks Laboratories (NSE:BROOKS) Is Making Moderate Use Of Debt

Brooks Laboratories Limited to Report Q4, 2020 Results on Jul 30, 2020

First quarter earnings released

New 90-day high: ₹44.65

Brooks Laboratories Limited to Report Q1, 2021 Results on Sep 15, 2020

Full year earnings released - ₹13.84 loss per share

New 90-day high - ₹37.80

Full year earnings released - ₹13.84 loss per share

CEO

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age